Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
218.34
-1.88 (-0.85%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
78
79
Next >
3 No-Brainer Dividend Stocks to Buy in September
September 13, 2025
The attraction of these dividend stocks isn't limited to their dividends.
Via
The Motley Fool
Topics
Intellectual Property
1 Green Flag for AbbVie (ABBV) Stock Right Now
September 12, 2025
Dividends are powerful portfolio boosters, and AbbVie is a dividend dynamo.
Via
The Motley Fool
Topics
Intellectual Property
Texas Rep. Julie Johnson Sold Up to $885K Worth of 3M Stock
September 12, 2025
Via
Benzinga
The Best Stocks to Invest $50,000 In Right Now
September 12, 2025
These stocks have what it takes to succeed over the long run.
Via
The Motley Fool
Topics
Artificial Intelligence
Government
Intellectual Property
AbbVie Logs Best Day In Over 7 Months As Wall Street Cheers Rinvoq Patent Deal Pushing Generics To 2037
September 12, 2025
Via
Stocktwits
Topics
Intellectual Property
AbbVie Stock Touches Record High After Company Dismisses Generic Competition For Rinvoq Till 2037: Wells Fargo Terms It A ‘Big Win’
September 11, 2025
Via
Stocktwits
This Is What Whales Are Betting On AbbVie
August 25, 2025
Via
Benzinga
AbbVie Seeks To Expand Psychiatry Pipeline By Acquiring Gilgamesh’s Lead Candidate For Up To $1.2B
August 25, 2025
Via
Stocktwits
Why AbbVie (ABBV) Stock Is Trading Up Today
September 11, 2025
Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 4.4% in the morning session after the company announced it settled litigation with generic drug manufacturers to extend patent protection for...
Via
StockStory
Topics
Intellectual Property
Why AbbVie Stock Is Jumping Today
September 11, 2025
AbbVie's growth prospects are now more secure thanks to its latest news.
Via
The Motley Fool
AbbVie Stock Breaks Out As Its Cash Cow Lives To Fight Another Day
September 11, 2025
AbbVie stock broke out Thursday after the pharma announced it had inked a deal that will stave off generic Rinvoq until 2037.
Via
Investor's Business Daily
Topics
Intellectual Property
What's going on in today's session: S&P500 gap up and gap down stocks
September 11, 2025
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Via
Chartmill
Why Is AbbVie Stock Trading Higher On Thursday?
September 11, 2025
AbbVie's settlement with generic rivals delays upadacitinib competition in the U.S. until at least 2037, supporting its long-term market presence.
Via
Benzinga
These S&P500 stocks that are showing activity before the opening bell on Thursday.
September 11, 2025
Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday?
Via
Chartmill
Global Growth Hits the Brakes: A Mixed Economic Picture Emerges for 2025 and Beyond
September 10, 2025
The global economy is bracing for a significant slowdown, with leading financial institutions projecting a challenging landscape for 2025 and the years to follow. A confluence of escalating trade...
Via
MarketMinute
Topics
Economy
Supply Chain
World Trade
1 Reason Every Investor Should Know About AbbVie (ABBV)
September 08, 2025
This company's past ability to extend patent-protected market exclusivity for its drugs bodes well for new investors.
Via
The Motley Fool
Topics
Intellectual Property
3 Dividend Stocks to Double Up on Right Now
September 07, 2025
Investors can feel good about upping their bets on these great dividend stocks.
Via
The Motley Fool
Topics
Energy
Intellectual Property
3 Stocks to Buy and Hold Forever
September 06, 2025
These stocks are built for the long run.
Via
The Motley Fool
Topics
Intellectual Property
Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
September 04, 2025
There is more to like than the dividend with these companies.
Via
The Motley Fool
Topics
Intellectual Property
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years
September 03, 2025
Via
Benzinga
1 Safe-and-Steady Stock with Promising Prospects and 2 Facing Headwinds
September 03, 2025
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Via
StockStory
Is Healthcare Setting Up to Be a Quiet Leader Into Year-End?
September 02, 2025
Over $11 billion flowed into the popular healthcare sector ETF XLV in Q2 alone, suggesting smart money is positioning for a potential rebound.
Via
MarketBeat
Topics
ETFs
5 High-Yield Dividend Stocks I Plan on Holding for the Next 10 Years or Longer
August 31, 2025
Selling these dividend stocks isn't on my radar at all.
Via
The Motley Fool
Topics
Energy
Intellectual Property
The Smartest Dividend Stocks to Buy With $500 Right Now
August 30, 2025
You won't need a lot of money up front to begin raking in dividends from these great stocks.
Via
The Motley Fool
Topics
World Trade
Deal Dispatch: PepsiCo, Sycamore, Dr. Phil, SSENSE, Bain's Chindata Lead M&A, Bankruptcy Moves
August 29, 2025
Deal activity this week included PepsiCo, Sycamore and Bain while the bankruptcy front included SSENSE and Dr. Phil.
Via
Benzinga
Topics
Bankruptcy
2 Reasons to Watch ABBV and 1 to Stay Cautious
August 29, 2025
AbbVie currently trades at $207.60 per share and has shown little upside over the past six months, posting a small loss of 0.7%. The stock also fell short of the S&P 500’s 9.2% gain during that...
Via
StockStory
Topics
Stocks
Supply Chain
As the Market Rotates, This Healthcare ETF Is Leading the Way
August 26, 2025
Health care saw some of the worst losses this year. But as the calendar turned to August, it's been leading the market higher. This ETF provides exposure.
Via
MarketBeat
Topics
ETFs
AbbVie Strikes $1.2 Billion Agreement For Next-Gen Psychedelic Depression Treatment
August 26, 2025
Via
Benzinga
3 Top Stocks to Build Your Portfolio Around
August 24, 2025
These great businesses can help patient investors beat the market.
Via
The Motley Fool
3 Unstoppable Dividend Stocks to Buy Right Now
August 23, 2025
Investors will get great dividends and more with these stocks.
Via
The Motley Fool
Topics
World Trade
< Previous
1
2
3
4
5
6
7
8
9
...
78
79
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.